Sanofi, GSK partner to develop vaccine against covid-19

In a rare collaboration, French biopharmaceutical giant Sanofi and its British rival GlaxoSmithKline plc (GSK) have partnered to develop a vaccine against covid-19, which if successful, will be commercialised in the second half of next year, the French firm said in a release. “This collaboration brings together two of the world’s largest vaccines companies. By...